CRCA vs CRCD: Leverage, Returns & Decay
Over three months to Nov 13, 2026, against its daily multiple, compounded, CRCA finished 3.1 points short and CRCD 1.6 points short.
- Return gap
- +11.5 pts1 year to Nov 13, 2026: CRCA ahead, total return
- Fee gap
- 0.55 ptsA year: CRCA 0.95%, CRCD 1.50%, per filings dated Aug 5, 2026 and Sep 25, 2026
- Overlap
- –No book read for both funds
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
CRCA −80.7%, CRCD −92.2%: CRCA +11.5 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in CRCA costs about $36.00 one way and $72.00 in and out, at a median spread of 0.72%. The 0.72% spread is CRCA’s 30-day median, from ProShares (fund page).
Fees over time
Hypothetical. $10,000 in CRCD for 10 years at 1.50% a year costs about $2,379 in fees and lost growth; CRCA at 0.95% would cost $1,542. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
CRCA returned −39.3% while 2 times CRCL's move would have been −26.2%. Data from Aug 14, 2026 to Nov 13, 2026.
CRCA returned −39.3% while 2 times CRCL's move would have been −26.2%. Data from Aug 14, 2026 to Nov 13, 2026.CRCD returned −23.6% while −2 times CRCL's move would have been +26.2%. Data from Aug 14, 2026 to Nov 13, 2026.
CRCD returned −23.6% while −2 times CRCL's move would have been +26.2%. Data from Aug 14, 2026 to Nov 13, 2026.IQ Leverage Score
How closely it delivered its daily multiple over 3 months, ranked against 498 leveraged ETFs at 2x, over three months and 74 inverse ETFs at 2x, over three months. 100 is best.
CRCA scores higher · Did it keep up with its own daily multiple, compounded day by day, over three months?
CRCA among the 498 leveraged ETFs at 2x, over three months
CRCD among the 74 inverse ETFs at 2x, over three months
A percentile among the 498 leveraged ETFs at 2x, over three months. CRCD is a percentile among the 74 inverse ETFs at 2x, over three months, a different set, so the two marks are not on one scale. Three months only, against the fund's own daily multiple; a different quarter can rank it very differently.
Key numbers
CRCA costs 0.55 points a year less; their one-year returns differ by 11.5 points; CRCA is far larger, $60m against $1.6m.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | −80.7% | −92.2% |
|---|---|---|
| What its daily multiple gave, 3 months | −36.2% | −22.0% |
| What it tracks | CRCL | CRCL |
| Expense ratio | 0.95% | 1.50% |
| Net assets, as of Nov 12, 2026 | $60m | $1.6m |
| Holdings in common | not published |
The numbers behind it
Net assets: $57m on Nov 13, 2026 for ProShares Ultra CRCL, and $1.6m on Nov 12, 2026 for T-REX 2X INVERSE CRCL DAILY TARGET ETF.
Side by side
Open the table
| Fund | ProShares Ultra CRCL · Aims to return twice the daily move of Circle Internet (CRCL) | T-REX 2X INVERSE CRCL DAILY TARGET ETF · Aims to return twice the opposite of the daily move of Circle Internet (CRCL) |
| Issuer | ProShares | T-REX |
| Sets out to return | +2x | −2x |
| Underlying asset | CRCL | CRCL |
| Segment | company | company |
| Fund returned, 3 months | −39.3% | −23.6% |
| Underlying returned, over that window | −13.1% | −13.1% |
| What the stated multiple implies, over that window | −26.2% | +26.2% |
| Difference from stated, over that window | −13.1 pts | −49.8 pts |
| Fund returned, 1 year | −80.7% | −92.2% |
| Difference from stated, over that window | −31.7 pts | −141.2 pts |
| Underlying volatility | 82% | 82% |
| Difference over the days both have traded | −13.1 pts | no shared window |
| Expense ratio | 0.95% | 1.50% |
| First traded | Aug 7, 2025 | Sep 26, 2025 |
| Net assets, CRCA as of Nov 13, 2026 and CRCD as of Nov 12, 2026 | $57m | $1.6m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the full table
| 1 month | −43.1% | +39.8% | −43.6% | +43.6% | +0.5 pts | −3.8 pts |
|---|---|---|---|---|---|---|
| 3 months | −39.3% | −23.6% | −26.2% | +26.2% | −13.1 pts | −49.8 pts |
| 6 months | −81.4% | +15.8% | −90.8% | +90.8% | +9.4 pts | −75.0 pts |
| 1 year | −80.7% | −92.2% | −49.0% | +49.0% | −31.7 pts | −141.2 pts |
| Since launch (Not the same days: CRCA Aug 2025 · CRCD Sep 2025) | −95.8% | −86.2% | not meaningful | +102.0% | not meaningful | −188.2 pts |
About CRCA
Over the three months to Nov 13, 2026, CRCA lost 39.3%, against −36.2% for twice CRCL's daily moves. Read the multiple against the whole window instead and 2 times CRCL's −13.1% implies −26.2%, which makes CRCA look 13.1 points short.
More
That is not the fund's objective, which is daily. Of that 13.1, daily compounding is −10.0 points, which any 2 times fund would show over the same path, and the fund itself is −3.1 points against 2 times each day's move, compounded. CRCA aims to return +2 times CRCL's move each day, then resets. Over one day it does that. Over longer periods the daily results compound, so the total is not +2 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run. CRCL moved at 82% annualized over that window. The more it moves, the further the two numbers separate.
About CRCD
Over the three months to Nov 13, 2026, CRCD lost 23.6%, against −22.0% for twice the inverse of CRCL's daily moves. Read the multiple against the whole window instead and −2 times CRCL's −13.1% implies +26.2%, which makes CRCD look 49.8 points short.
More
Of that 49.8, daily compounding is −48.2 points, which any −2 times fund would show over the same path, and the fund itself is −1.6 points against −2 times each day's move, compounded. CRCD aims to return -2 times CRCL's move each day, then resets. Over longer periods the daily results compound, so the total is not -2 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run.
Questions people ask
Which came closer to its daily multiple, CRCA or CRCD?
Over the window to Nov 13, 2026, CRCA finished 13.1 points from what its multiple implies and CRCD finished 49.8 points from its own, so CRCA came closer. Neither number predicts the next window: it depends on how much the underlying moves about.
Are CRCA and CRCD levered on the same thing?
Yes. Both are levered on Circle Internet, CRCA at +2 times and CRCD at -2 times the daily move.
Which one decays faster, CRCA or CRCD?
Decay follows how much the underlying moves about. Over this window CRCA’s moved at 82% annualized and CRCD’s at 82%, so CRCA has the rougher ride and, at the same multiple, loses more to compounding.
Can I hold CRCA or CRCD for a year?
Both reset every day, so the multiple in the name applies to a single day, and daily results compound. Over a year the total is not the multiple times the year’s move; after a fall and recovery it is lower.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, CRCA against CRCD, data as of Nov 13, 2026. https://etfiq.com/compare/leverage/crca-vs-crcd
ETFIQ. (Nov 13, 2026). CRCA against CRCD. Retrieved from https://etfiq.com/compare/leverage/crca-vs-crcd
[CRCA against CRCD (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/leverage/crca-vs-crcd)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.